4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000020
COO and SVP, R&D acquired 44,871 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Johnston Lloyd P. · COO and SVP, R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-11 | Exercise or conversion : show line 1 in the form | +44,871 | $0.63 | $28,269 | 102,605 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-11 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −44,871 | 0 | D |
Loading xslF345X03/wf-form4_161351699826212.xml…